Bayer could settle the Roundup cancer litigation, but the drama is far from over

by Everlee Megan

Roundup weed killer, which is the subject of thousands of lawsuits in the U.S., is pictured on sale in Los Angeles on Sept. 1, 2019.

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today.

Bayer is setting aside as much $10.9 billion to settle current and future lawsuits over the allegedly carcinogenic effects of Roundup, the weed killer it inherited from Monsanto. As Deutsche Bank analysts wrote in a Thursday note, the class agreement “provides a reasonable degree of finality to the litigation issue.”

You may also like

Leave a Comment